Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Proteasome activator subunit 2 pseudogene 3 (PSME2P3) is a processed pseudogene located in the human genome (Ensembl: ENSG00000248988) that arises from the gene encoding the proteasome activator subunit 2 (PSME2, PA28β)[1][8][10]. As a pseudogene, PSME2P3 contains sequence similarity to the functional PSME2 gene but lacks the capacity to encode a functional protein product. Such pseudogenes typically do not produce biologically active proteins and generally have no established role in health or disease; instead, they remain as non-functional genomic elements[1][5][8]. There is no evidence indicating that PSME2P3 has a role as a therapeutic target, biomarker, or effector in any known disease process.
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Proteasome activator subunit 2 pseudogene 3 (PSME2P3).